Safety and normal vision data study with Neos device
Part of Brain & nervous system, Eyes & vision clinical trials.
This study is testing a device called Neos to gather safety information and normal vision data. It includes both healthy volunteers and people with eye or brain conditions, helping researchers understand how vision and eye movements work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 3 years old.
- You or your legal guardian must sign a consent form to join.
- Your vision with glasses or contacts must be fairly good (better than 20/25 on a standard eye chart).
- If you have eye or brain disease, you may join if your vision is not extremely poor (better than detecting hand motion).
- You cannot be on certain medications that affect eye movements, like sedatives or stimulants (such as Ritalin or alcohol).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how blood flows in the optic nerve (the nerve that carries visual information from the eye to the brain) using advanced imaging. It aims to better understand different optic nerve conditions, which may help improve diagnosis and treatment in the future.
This trial uses an eye-tracking camera or software to measure how your eyes move while you do simple tasks. It’s meant to test whether the eye-tracking system can reliably collect useful movement data in people like you.
This study tests how consistent a new eye-test device (AdaptDx Pro) is at measuring a specific way your eyes adapt to the dark. It is only for people with healthy eyes and normal vision, and it will help make sure the device works reliably.
This study looks at how glaucoma affects daily activities, like driving. It compares people with glaucoma to healthy volunteers to understand how the disease impacts everyday tasks, which may help with future care and safety recommendations.
This early-stage study uses virtual reality tasks to check how well a person can move and function using their eyesight. It may help researchers measure vision abilities in a way that could guide future care for retinal disease.
This study collects normal vision data from healthy adults using a device called MAIA microperimeter, which tests how your retina and eye movements respond. It helps create a baseline for comparing people with eye problems in the future.
Hear when a new Neuro-Ophthalmology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.